It is our pleasure to inform you about the creation of two unique doctoral programmes created in collaboration with the National Institute for Cancer Research (NICR) and under its patronage. The two programmes are Molecular and Translational Medicine at the Palack\u00fd University, Olomouc, and Experimental and Clinical Oncology at the Charles University.<\/b><\/p>\nMolecural and translation medicine<\/b><\/h3>\n
This programme is guaranteed and accredited thanks to the efforts of experts from the Institute for Molecular and Translational Medicine of the Faculty of Medicine of Palack\u00fd University, Olomouc (<\/span>www.imtm.cz<\/span><\/a>) and the EATRIS-CZ (<\/span>www.eatris.cz<\/span><\/a>), a large research infrastructure for translational medicine, under the leadership of Mari\u00e1n Hajd\u00fach, head of the field board and medical director of the NICR.<\/span><\/p>\n The doctoral programme Molecular and Translational Medicine focuses on understanding the molecular foundation of human diseases and the possibilities of their diagnosis and treatment. In particular, it searches for new molecular targets, biomarkers of diseases, and innovative therapeutic methods, while developing healthcare informatics and personalised medicine that targets cancers and infectious,<\/span><\/p>\n neurogenerative, and inflammatory diseases.<\/span><\/p>\n Graduates of this programme will be able to independently analyse a problem, define research goals, prepare research projects, choose appropriate methods, organise data collection, and evaluate and publish results of this work. The programme also aims at teaching graduates how to clearly, convincingly, and understandably present scientific results and share their knowledge with both academic and general public.<\/span><\/p>\n Special attention is paid to translational research and \u2018bed-to-bench\u2019 approach, i.e., to a fast transfer of research results from laboratories to medical practice and the end recipients, that is, patients.<\/span><\/p>\n Doctoral programme Molecular and Translational Medicine responds to the need for increased interdisciplinary and intersectoral collaboration and the desirability of collaboration between clinical centres and the application sphere by entrusting a greater role in research to academic institutions. It is focused on developing in its graduates the ability to implement longer-term projects that require excellent scientific<\/span><\/p>\n facilities. Such facilities should be sought through closer collaboration with not only healthcare facilities (clinical studies) but also in collaboration with institutions that conduct basic and applied (translational) research.<\/span><\/p>\n Last but not least, the aim of the programme is to link the research centres and teams active in areas closely related to this programme: working together, they should be able to successfully set new research directions, develop advanced technologies, and reach their full potential in terms of winning national and international grants.<\/span><\/p>\n The graduates of doctoral programme Molecular and Translational Medicine will, in the future, fill a gap in the job market where there is a clear lack of interdisciplinary experts capable of understanding the needs of translational research in medicine who also have a sufficient grasp of the particular processes required in realisation of projects aimed at a practical application of research results in practice.<\/span><\/p>\nWhat we offer<\/b><\/h4>\n
What makes us different<\/b><\/h4>\n
Why we are looking for you<\/b><\/h4>\n